• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板纤维蛋白能否改善药物相关性颌骨骨坏死手术治疗后的愈合?一项初步研究。

Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study.

机构信息

School of Dentistry, Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.

School of Dentistry, Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):390-403. doi: 10.1016/j.oooo.2018.06.007. Epub 2018 Jun 30.

DOI:10.1016/j.oooo.2018.06.007
PMID:30108028
Abstract

OBJECTIVE

The aim of this study was to evaluate the efficacy of platelet-rich fibrin (PRF) after bone surgery compared to surgery alone in the treatment of medication-related osteonecrosis of the jaw (MRONJ).

STUDY DESIGN

A total of 47 patients with diagnosis of stage II or III of MRONJ were recruited at the Academic Hospital of Magna Graecia University of Catanzaro and allocated to 2 groups: In the first, patients were treated with PRF in addition to surgery (PRF group), in the other, only bone surgery was performed (non-PRF group). Fisher's exact and Student t tests were used to evaluate differences between the 2 surgical protocols in terms of mucosal integrity, absence of infection, and pain evaluation at scheduled follow-ups of 1 month (T1), 6 months (T2), and 1 year (T3).

RESULTS

Analysis of mucosal integrity, absence of infection, and pain evaluation showed a significant difference between the 2 groups in favor of PRF only at T1 (P < .05), whereas no differences were determined at T2 and T3 (P > .05).

CONCLUSIONS

Our results suggested that local application of PRF after bone surgery may improve the quality of life limited to the short-term follow-up and reduce pain and postoperative infections.

摘要

目的

本研究旨在评估富血小板纤维蛋白(PRF)在颌骨骨髓炎(MRONJ)治疗中的疗效,与单纯手术相比。

研究设计

共有 47 名诊断为 II 期或 III 期 MRONJ 的患者在卡坦扎罗 Magna Graecia 大学附属医院接受治疗,并分为两组:第一组患者在手术治疗的基础上添加 PRF(PRF 组),另一组仅接受骨手术治疗(非 PRF 组)。Fisher 确切概率检验和学生 t 检验用于评估两组手术方案在预定随访 1 个月(T1)、6 个月(T2)和 1 年(T3)时的黏膜完整性、无感染和疼痛评估方面的差异。

结果

分析黏膜完整性、无感染和疼痛评估显示,PRF 组在 T1 时的结果明显优于非 PRF 组(P <.05),而在 T2 和 T3 时没有差异(P >.05)。

结论

我们的结果表明,在骨手术后局部应用 PRF 可能会提高生活质量,仅限于短期随访,并减轻疼痛和术后感染。

相似文献

1
Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study.富血小板纤维蛋白能否改善药物相关性颌骨骨坏死手术治疗后的愈合?一项初步研究。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):390-403. doi: 10.1016/j.oooo.2018.06.007. Epub 2018 Jun 30.
2
Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.富含血小板纤维蛋白(A-PRF)和可注射性富含血小板纤维蛋白(i-PRF)在治疗大剂量药物相关性颌骨坏死(MRONJ)中的应用:5 年随访病例报告。
Indian J Dent Res. 2020 Sep-Oct;31(5):813-818. doi: 10.4103/ijdr.IJDR_689_19.
3
Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin.使用辅助白细胞和血小板丰富纤维蛋白治疗药物相关性颌骨骨髓炎的手术治疗的有前景的结果。
BMC Oral Health. 2021 Dec 1;21(1):613. doi: 10.1186/s12903-021-01965-7.
4
Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?在富血小板纤维蛋白中添加骨形态发生蛋白2是否能改善药物相关性颌骨坏死治疗后的愈合情况?
J Oral Maxillofac Surg. 2017 Jun;75(6):1176-1184. doi: 10.1016/j.joms.2016.12.005. Epub 2016 Dec 11.
5
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.富血小板纤维蛋白在药物相关性颌骨坏死中的应用:一项病例系列研究。
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89. doi: 10.1016/j.jormas.2019.02.011. Epub 2019 Feb 20.
6
The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): a retrospective observational study.富白细胞-血小板纤维蛋白(L-PRF)在药物相关性颌骨坏死(MRONJ)治疗中的辅助应用:一项回顾性观察研究。
Oral Maxillofac Surg. 2024 Dec;28(4):1605-1615. doi: 10.1007/s10006-024-01291-6. Epub 2024 Sep 3.
7
Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients.使用富血小板纤维蛋白治疗颌骨坏死:15例患者的前瞻性研究
Int J Oral Maxillofac Surg. 2016 Oct;45(10):1256-60. doi: 10.1016/j.ijom.2016.04.010. Epub 2016 May 11.
8
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.
9
Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.富含纤维蛋白的血小板和白细胞(L-PRF)在使用唑来膦酸的手术口腔程序中的组织修复中的疗效:病例对照研究。
Oral Maxillofac Surg. 2023 Sep;27(3):507-512. doi: 10.1007/s10006-022-01094-7. Epub 2022 Jun 24.
10
Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.富血小板纤维蛋白可能降低接受口服双膦酸盐治疗的拔牙患者延迟恢复的风险:一项试验研究。
Clin Oral Investig. 2017 Sep;21(7):2165-2172. doi: 10.1007/s00784-016-2004-z. Epub 2016 Nov 11.

引用本文的文献

1
Autologous Platelet Concentrates in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review.自体血小板浓缩物在药物相关性颌骨坏死治疗中的应用:一项系统评价
Medicina (Kaunas). 2025 Aug 21;61(8):1496. doi: 10.3390/medicina61081496.
2
Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study.不使用和使用高级富血小板纤维蛋白治疗药物相关性颌骨坏死:一项回顾性临床研究
J Funct Biomater. 2025 May 14;16(5):180. doi: 10.3390/jfb16050180.
3
Efficacy of platelet-rich-fibrin for the treatment of alveolar osteitis: a systematic review and meta-analysis.
富血小板纤维蛋白治疗干槽症的疗效:一项系统评价与Meta分析
Med Oral Patol Oral Cir Bucal. 2025 May 1;30(3):e345-e353. doi: 10.4317/medoral.26801.
4
Effect of active oxygen gel on the clinical parameters of MRONJ.活性氧凝胶对MRONJ临床参数的影响。
Saudi Dent J. 2024 Nov;36(11):1456-1458. doi: 10.1016/j.sdentj.2024.09.003. Epub 2024 Sep 3.
5
Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw.自体血小板浓缩物作为颌骨药物相关性骨坏死外科治疗的辅助手段
Periodontol 2000. 2025 Feb;97(1):287-307. doi: 10.1111/prd.12608. Epub 2024 Sep 30.
6
The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): a retrospective observational study.富白细胞-血小板纤维蛋白(L-PRF)在药物相关性颌骨坏死(MRONJ)治疗中的辅助应用:一项回顾性观察研究。
Oral Maxillofac Surg. 2024 Dec;28(4):1605-1615. doi: 10.1007/s10006-024-01291-6. Epub 2024 Sep 3.
7
A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials.激光光生物调节剂量学与治疗方案在药物相关性颌骨坏死管理中的系统评价:对未来随机对照临床试验的合理共识
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1011. doi: 10.3390/ph17081011.
8
Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.富含血小板纤维蛋白治疗颌骨药物相关性骨坏死和放射性骨坏死患者的疗效评估
J Clin Med. 2024 Jun 14;13(12):3473. doi: 10.3390/jcm13123473.
9
A systematic review of oral wound healing indices.口腔伤口愈合指数的系统评价
PLoS One. 2024 Feb 8;19(2):e0290050. doi: 10.1371/journal.pone.0290050. eCollection 2024.
10
Use of Leukocyte- and Platelet-Rich Fibrin to Prevent Osteonecrosis of the Jaws Associated with the Use of Bisphosphonate Therapy: A Case Series.使用富含白细胞和血小板的纤维蛋白预防与双膦酸盐治疗相关的颌骨坏死:病例系列
J Maxillofac Oral Surg. 2023 Dec;22(4):1159-1165. doi: 10.1007/s12663-023-02001-7. Epub 2023 Sep 7.